Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 17 04:00PM ET
2.12
Dollar change
-0.05
Percentage change
-2.30
%
IndexRUT P/E- EPS (ttm)-0.79 Insider Own1.91% Shs Outstand114.73M Perf Week11.58%
Market Cap243.23M Forward P/E- EPS next Y-0.26 Insider Trans-9.24% Shs Float112.54M Perf Month6.00%
Income-59.29M PEG- EPS next Q-0.32 Inst Own70.99% Short Float19.27% Perf Quarter-23.19%
Sales301.87M P/S0.81 EPS this Y87.97% Inst Trans-1.46% Short Ratio9.54 Perf Half Y17.78%
Book/sh-0.72 P/B- EPS next Y13.10% ROA-10.17% Short Interest21.69M Perf Year-57.77%
Cash/sh2.26 P/C0.94 EPS next 5Y- ROE- 52W Range1.43 - 5.63 Perf YTD-36.34%
Dividend Est.- P/FCF- EPS past 5Y4.73% ROI-26.65% 52W High-62.34% Beta0.70
Dividend TTM- Quick Ratio1.05 Sales past 5Y-2.24% Gross Margin39.78% 52W Low48.24% ATR (14)0.16
Dividend Ex-Date- Current Ratio1.17 EPS Y/Y TTM79.87% Oper. Margin-56.53% RSI (14)48.12 Volatility8.04% 7.73%
Employees306 Debt/Eq- Sales Y/Y TTM64.63% Profit Margin-19.64% Recom1.67 Target Price8.33
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q185.78% Payout- Rel Volume0.64 Prev Close2.17
Sales Surprise-5.68% EPS Surprise427.29% Sales Q/Q137.58% EarningsMay 09 AMC Avg Volume2.27M Price2.12
SMA200.50% SMA50-5.22% SMA200-28.09% Trades Volume1,454,940 Change-2.30%
Date Action Analyst Rating Change Price Target Change
Nov-17-23Initiated Robert W. Baird Outperform $11
Nov-08-23Downgrade Maxim Group Buy → Hold
Jul-24-23Initiated Citigroup Buy $12
May-01-23Initiated Truist Buy $24
Mar-28-23Upgrade UBS Neutral → Buy $11
Jun-14-22Initiated UBS Neutral $7
Mar-07-22Downgrade JP Morgan Overweight → Neutral $15
Jul-16-20Initiated BofA Securities Neutral $20
Apr-17-20Initiated SunTrust Buy $26
Aug-13-19Initiated Mizuho Buy
May-13-24 09:23AM
May-10-24 04:45PM
May-09-24 05:15PM
04:12PM
04:01PM
07:30AM Loading…
07:30AM
May-08-24 09:00AM
May-01-24 04:30PM
Apr-24-24 10:02AM
Apr-08-24 08:30AM
Mar-16-24 03:35PM
Mar-14-24 06:28PM
07:15AM
Mar-13-24 05:32PM
04:13PM
04:01PM Loading…
04:01PM
Mar-05-24 04:01PM
Mar-04-24 01:00AM
Feb-23-24 05:33PM
Feb-21-24 08:30AM
Feb-06-24 05:16PM
Feb-05-24 08:00AM
Jan-23-24 11:37AM
Jan-22-24 03:41PM
08:38AM
01:15AM
Jan-18-24 04:05PM
Jan-12-24 03:06AM
Jan-04-24 08:00AM
Jan-03-24 09:00AM
08:29AM Loading…
Jan-02-24 08:29AM
Dec-28-23 03:45PM
11:07AM
Dec-27-23 05:07PM
01:06PM
Dec-26-23 04:01PM
Dec-24-23 09:45AM
Dec-22-23 05:00PM
Dec-11-23 08:30AM
Dec-07-23 05:55PM
Dec-06-23 04:00AM
Nov-28-23 11:16AM
Nov-10-23 03:15PM
Nov-07-23 03:37PM
10:46AM
10:19AM
Nov-06-23 05:13PM
04:43PM
04:07PM
Nov-03-23 08:30AM
Nov-02-23 08:00PM
Nov-01-23 10:01AM
Oct-30-23 06:00PM
05:43PM
Oct-27-23 03:07PM
Oct-24-23 07:41PM
Oct-14-23 12:30PM
Oct-11-23 10:42AM
Oct-09-23 09:49AM
Oct-05-23 04:45PM
08:30AM
Oct-04-23 08:30AM
Oct-02-23 09:00AM
Sep-27-23 09:10AM
Sep-26-23 10:53AM
Sep-25-23 08:30AM
Sep-22-23 09:00PM
Sep-08-23 09:05AM
08:31AM
Sep-01-23 06:51PM
04:01PM
Aug-31-23 04:01PM
Aug-22-23 05:35PM
Aug-03-23 07:43PM
Aug-02-23 05:15PM
04:12PM
04:01PM
Jul-26-23 04:05PM
Jul-21-23 05:30PM
Jul-20-23 04:04PM
Jul-13-23 08:30AM
Jul-03-23 08:52AM
08:30AM
Jun-26-23 09:08PM
Jun-21-23 08:00PM
Jun-16-23 10:00AM
08:30AM
07:01AM
Jun-15-23 01:24PM
10:49AM
07:07AM
Jun-06-23 01:34PM
Jun-05-23 05:30PM
09:46AM
Jun-01-23 09:37AM
09:07AM
08:33AM
08:30AM
May-31-23 01:34PM
01:13PM
Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wahlstrom MatsDirectorFeb 01 '24Option Exercise1.6759,988100,00099,988Feb 05 07:03 PM
Lanfear Dennis MPresident & CEONov 22 '23Option Exercise1.42299,940425,015954,793Nov 24 04:04 PM
Lanfear Dennis MPresident & CEONov 22 '23Sale2.02223,100449,770731,693Nov 24 04:04 PM